Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership701 shares
Latest Disclosed Value $ 9,821
Signaturefd, Llc reports 43.94% increase in ownership of AVNS / Avanos Medical, Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 701 shares of Avanos Medical, Inc. (US:AVNS) valued at $9,821 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 487 shares of Avanos Medical, Inc.. This represents a change in shares of 43.94% during the quarter. The current value of the position is $17,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F AVANOS MED COM 05350V106 701 214 43.94 10 80.00 0.0002
2026-01-20 2025-12-31 13F AVANOS MED COM 05350V106 487 329 208.23 5 400.00 0.0001
2025-10-21 2025-09-30 13F AVANOS MED COM 05350V106 158 -119 -42.96 2 -66.67 0.0000
2025-07-16 2025-06-30 13F AVANOS MED COM 05350V106 277 211 319.70 3 0.0001
2025-05-02 2025-03-31 13F AVANOS MED COM 05350V106 66 66 1 0.0000
2024-10-21 2024-09-30 13F AVANOS MED COM 05350V106 0 -20 -100.00 0 0.0000
2024-07-29 2024-06-30 13F AVANOS MED COM 05350V106 20 20 0 0.0000
2024-05-03 2024-03-31 13F AVANOS MED COM 05350V106 0 -460 -100.00 0 -100.00
2024-02-01 2023-12-31 13F AVANOS MED COM 05350V106 460 460 10 0.0002
2023-08-01 2023-06-30 13F AVANOS MED COM 05350V106 0 -719 -100.00 0 -100.00
2023-04-28 2023-03-31 13F AVANOS MED COM 05350V106 719 371 106.61 21 133.33 0.0006
2023-01-30 2022-12-31 13F AVANOS MED COM 05350V106 348 74 27.01 9 50.00 0.0003
2022-11-08 2022-09-30 13F AVANOS MED COM 05350V106 274 49 21.78 6 0.00 0.0002
2022-08-10 2022-06-30 13F AVANOS MED COM 05350V106 225 100 80.00 6 50.00 0.0002
2022-05-02 2022-03-31 13F AVANOS MED COM 05350V106 125 -115 -47.92 4 -50.00 0.0001
2022-01-25 2021-12-31 13F AVANOS MED COM 05350V106 240 72 42.86 8 60.00 0.0002
2021-10-28 2021-09-30 13F AVANOS MED COM 05350V106 168 13 8.39 5 -16.67 0.0002
2021-07-26 2021-06-30 13F AVANOS MED COM 05350V106 155 -2 -1.27 6 -14.29 0.0002
2021-04-30 2021-03-31 13F AVANOS MED COM 05350V106 157 13 9.03 7 0.00 0.0003
2021-02-11 2020-12-31 13F AVANOS MED COM 05350V106 144 -14 -8.86 7 40.00 0.0003
2020-11-03 2020-09-30 13F AVANOS MED COM 05350V106 158 14 9.72 5 25.00 0.0003
2020-07-30 2020-06-30 13F AVANOS MED COM 05350V106 144 26 22.03 4 33.33 0.0002
2020-04-23 2020-03-31 13F AVANOS MED COM 05350V106 118 106 883.33 3 0.0003
2020-02-05 2019-12-31 13F AVANOS MED COM 05350V106 12 -1,070 -98.89 0 -100.00
2019-10-16 2019-09-30 13F AVANOS MED COM 05350V106 1,082 312 40.52 41 20.59 0.0034
2019-07-31 2019-06-30 13F AVANOS MED COM 05350V106 770 -25 -3.14 34 0.00 0.0029
2019-05-09 2019-03-31 13F AVANOS MED COM 05350V106 795 0 0.00 34 -5.56 0.0029
2019-02-13 2018-12-31 13F AVANOS MED COM 05350V106 795 734 1,203.28 36 800.00 0.0034
2018-11-14 2018-09-30 13F AVANOS MED COM 05350V106 61 -65 -51.59 4 -42.86 0.0004
2018-08-14 2018-06-30 13F HALYARD HEALTH COM 40650V100 126 102 425.00 7 600.00 0.0008
2018-05-08 2018-03-31 13F HALYARD HEALTH COM 40650V100 24 24 1 0.0001
2017-02-14 2016-12-31 13F HALYARD HEALTH COM 40650V100 0 -170 -100.00 0 -100.00
2016-11-14 2016-09-30 13F HALYARD HEALTH COM 40650V100 170 50 41.67 6 50.00 0.0009
2016-07-29 2016-06-30 13F HALYARD HEALTH COM 40650V100 120 -20 -14.29 4 0.00 0.0006
2016-05-12 2016-03-31 13F HALYARD HEALTH COM 40650V100 140 -97 -40.93 4 -50.00 0.0007
2016-01-22 2015-12-31 13F HALYARD HEALTH COM 40650V100 237 -50 -17.42 8 0.00 0.0015
2015-10-23 2015-09-30 13F HALYARD HEALTH COM 40650V100 287 66 29.86 8 -11.11 0.0018
2015-07-15 2015-06-30 13F HALYARD HEALTH COM 40650V100 221 -5 -2.21 9 -18.18 0.0020
2015-04-15 2015-03-31 13F HALYARD HEALTH COM 40650V100 226 13 6.10 11 10.00 0.0027
2015-02-13 2014-12-31 13F HALYARD HEALTH COM 40650V100 213 213 10 0.0025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.